SLC2A1 and neoplasm: Contrastingly, both tumor cells and immune cells were substantially suppressed by KL-11743 treatment due to the simultaneous inhibition of GLUT1 and GLUT3, leading to universal glucose uptake blockade (Fig. 3l, m and Supplementary Figs. 16–18).